𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reply: Heart valve abnormalities in Parkinson’s disease treated with dopamine agonists

✍ Scribed by E. Růžička; H. Línková; M. Pěnička; O. Ulmanová; L. Nováková; J. Roth

Book ID
106094095
Publisher
Springer
Year
2008
Tongue
English
Weight
120 KB
Volume
255
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis of heart valve abnormaliti
Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists
✍ Gregor Simonis; Joerg T. Fuhrmann; Ruth H. Strasser 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract Valvular heart disease in patients being treated with ergot‐derivative dopamine agonists (Ergot‐DA) for Parkinson's disease has been reported to occur as a consequence of serotonine receptor stimulation. Goal of this analysis was to estimate the incidence of those changes from recently

Valvular heart disease in Parkinson's di
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
✍ Ji-Youn Kim; Eun Joo Chung; Seung Woo Park; Won Yong Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Valvular heart disease, associated with ergot derivative dopamine agonists, has been reported in patients with Parkinson's disease (PD). There are few comparative studies on the frequency, severity, and dose dependency of valvular disease associated with ergot derivatives. We analyzed these factors